- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Soleno Therapeutics Faces Shareholder Lawsuit Investigation
Halper Sadeh LLC probing whether company is obtaining a fair price in potential sale
Apr. 6, 2026 at 2:54pm
Got story updates? Submit your updates here. ›
A shareholder lawsuit investigation probes whether Soleno Therapeutics is obtaining fair value in a potential sale.NYC TodayHalper Sadeh LLC, a national shareholder rights litigation firm, has announced that it is investigating whether the proposed sale of Soleno Therapeutics, Inc. to a third party is obtaining a fair price for Soleno shareholders. The investigation focuses on the financial and other benefits to Soleno's board of directors.
Why it matters
Shareholder lawsuits over mergers and acquisitions are common, as investors seek to ensure they are receiving the maximum value for their shares. This investigation could lead to a lawsuit that delays or alters the terms of Soleno's potential sale.
The details
Halper Sadeh LLC is examining whether Soleno's board breached its fiduciary duties by failing to maximize the value of the company for the benefit of shareholders. The firm is also investigating the adequacy of the proposed transaction consideration.
- The investigation was announced on April 6, 2026.
The players
Halper Sadeh LLC
A national shareholder rights litigation firm that investigates potential breaches of fiduciary duty by corporate boards of directors.
Soleno Therapeutics, Inc.
A biopharmaceutical company focused on the development and commercialization of novel therapeutics for the treatment of rare diseases.
The takeaway
This investigation highlights the importance of ensuring shareholders receive fair value in mergers and acquisitions, and the willingness of law firms to challenge deals they believe undervalue a company.
